Abstract:Background: Several studies have demonstrated a possible association between specific enteric infections and an increased incidence of Inflammatory Bowel Disease (IBD).Few studies, however, have examined the role of non-clostridial enteric infections complicating preexisting IBD.The objective of this study was to investigate the etiology and predictors of enteric infection detected by multiplex PCR stool testing in patients with IBD.Methods: We performed a cross-sectional analysis of 9,403 inpatients and outpatients who underwent 13,231 stool tests with a FilmArray gastrointestinal pathogen PCR panel (BioFire Diagnostics, Salt Lake City, UT) during an episode of diarrhea from March 2015 and May 2017.Repeat tests within 6 months were excluded.Our primary outcome was the presence of any positive gastrointestinal pathogen PCR panel according to IBD subtype.Results: 277 patients with Crohn's disease (CD), 300 patients with Ulcerative colitis (UC), and 8,826 patients without IBD underwent 454, 503, and 12,275 stool tests, respectively (Table 1).Compared to patients without IBD, patients with IBD were less likely to test positive for an enteric infection (26.6% non-IBD vs 18.1% CD, p<0.001; 16.1% UC, p<0.001).Among those with a positive test, patients with IBD were older than those without IBD (median 30.6 years for non-IBD vs 33.0 for CD, p=0.045; 49.6 for UC, p<0.001).Compared to patients without IBD, patients with CD had a higher prevalence of norovirus (17.4% vs 24.6%, p=0.05) and Campylobacter (7.6% vs 13.1%, p=0.043), and a lower prevalence of parasites (6.1% vs 0.8%, p=0.01,Table 2).Compared to patients without IBD, patients with UC had a lower prevalence of parasites (6.1% vs 0.9%, p=0.014) and viruses (31.9% vs 16.5%, p=0.007), specifically norovirus (17.4% vs 7.8%, p=0.019), and a higher prevalence of bacteria (62.1% vs 82.6%, p<0.001), specifically Campylobacter (7.6% vs 13.9%, p=0.013),Plesiomonas (0.7% vs 2.6%, p=0.049), and Escherichia coli species (47.6% vs 64.3%, p<0.001), including Enteroaggregative E.coli (EAEC; 13.5% vs 20.9%, p=0.028), and Enteropathogenic E.coli (EPEC; 22.1% vs 33.9%, p=0.004).Conclusions: Enteric infection was common in symptomatic patients with IBD.These data suggest that viruses, such as norovirus, may play an important role in modulating the mucosal immune response in patients with CD; while bacterial pathogens, such as E.coli species, may play an important role in modulating the mucosal immune response in patients with UC.Further study is required to investigate the specific interaction between enteric infections, mucosal immunity, and the phenotypic presentations of IBD.

Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease

Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases

Potential Role of Th17 Cells in the Pathogenesis of Inflammatory Bowel Disease.

Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera

Hyperactivated B Cells in Human Inflammatory Bowel Disease

Food-specific IgGs Are Highly Increased in the Sera of Patients with Inflammatory Bowel Disease and Are Clinically Relevant to the Pathogenesis

A novel unconventional T cell population enriched in Crohn's disease

Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

Systemic Toll-like Receptor Ligands Modify B-cell Responses in Human Inflammatory Bowel Disease.

Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.

Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease

Immunoglobulin Subtype-Coated Bacteria Are Correlated with the Disease Activity of Inflammatory Bowel Disease

CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease

Inflammatory bowel diseases influence major histocompatibility complex class I (MHC I) and II compartments in intestinal epithelial cells

Serum bacterial toxins are related to the progression of inflammatory bowel disease

Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c−CCR2−CX3CR1− counterparts, are expanded in inflammatory bowel disease

Targeting T and B Lymphocytes in Inflammatory Bowel Diseases: Lessons from Clinical Trials

REPERTOIRE ANALYSIS OF MEMORY T-CELL RECEPTORS IN JAPANESE PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Sa1187 - Alternation of Intestinal Epithelial Stem Cells Compartment in Response to Inflammation from Patients with Crohn's Disease

Simultaneous Profiling of the Blood and Gut T and B Cell Repertoires in Crohn's Disease and Symptomatic Controls Illustrates Tissue-specific Alterations in the Immune Repertoire of Crohn's Disease Patients

Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease